Cargando…
Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19
The contribution of CD4(+) T cells to protective or pathogenic immune responses to SARS-CoV-2 infection remains unknown. Here, we present single-cell transcriptomic analysis of >100,000 viral antigen-reactive CD4(+) T cells from 40 COVID-19 patients. In hospitalized patients compared to non-hospi...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534589/ https://www.ncbi.nlm.nih.gov/pubmed/33096020 http://dx.doi.org/10.1016/j.cell.2020.10.001 |
_version_ | 1783590338892398592 |
---|---|
author | Meckiff, Benjamin J. Ramírez-Suástegui, Ciro Fajardo, Vicente Chee, Serena J. Kusnadi, Anthony Simon, Hayley Eschweiler, Simon Grifoni, Alba Pelosi, Emanuela Weiskopf, Daniela Sette, Alessandro Ay, Ferhat Seumois, Grégory Ottensmeier, Christian H. Vijayanand, Pandurangan |
author_facet | Meckiff, Benjamin J. Ramírez-Suástegui, Ciro Fajardo, Vicente Chee, Serena J. Kusnadi, Anthony Simon, Hayley Eschweiler, Simon Grifoni, Alba Pelosi, Emanuela Weiskopf, Daniela Sette, Alessandro Ay, Ferhat Seumois, Grégory Ottensmeier, Christian H. Vijayanand, Pandurangan |
author_sort | Meckiff, Benjamin J. |
collection | PubMed |
description | The contribution of CD4(+) T cells to protective or pathogenic immune responses to SARS-CoV-2 infection remains unknown. Here, we present single-cell transcriptomic analysis of >100,000 viral antigen-reactive CD4(+) T cells from 40 COVID-19 patients. In hospitalized patients compared to non-hospitalized patients, we found increased proportions of cytotoxic follicular helper cells and cytotoxic T helper (T(H)) cells (CD4-CTLs) responding to SARS-CoV-2 and reduced proportion of SARS-CoV-2-reactive regulatory T cells (T(REG)). Importantly, in hospitalized COVID-19 patients, a strong cytotoxic T(FH) response was observed early in the illness, which correlated negatively with antibody levels to SARS-CoV-2 spike protein. Polyfunctional T(H)1 and T(H)17 cell subsets were underrepresented in the repertoire of SARS-CoV-2-reactive CD4(+) T cells compared to influenza-reactive CD4(+) T cells. Together, our analyses provide insights into the gene expression patterns of SARS-CoV-2-reactive CD4(+) T cells in distinct disease severities. |
format | Online Article Text |
id | pubmed-7534589 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75345892020-10-06 Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19 Meckiff, Benjamin J. Ramírez-Suástegui, Ciro Fajardo, Vicente Chee, Serena J. Kusnadi, Anthony Simon, Hayley Eschweiler, Simon Grifoni, Alba Pelosi, Emanuela Weiskopf, Daniela Sette, Alessandro Ay, Ferhat Seumois, Grégory Ottensmeier, Christian H. Vijayanand, Pandurangan Cell Article The contribution of CD4(+) T cells to protective or pathogenic immune responses to SARS-CoV-2 infection remains unknown. Here, we present single-cell transcriptomic analysis of >100,000 viral antigen-reactive CD4(+) T cells from 40 COVID-19 patients. In hospitalized patients compared to non-hospitalized patients, we found increased proportions of cytotoxic follicular helper cells and cytotoxic T helper (T(H)) cells (CD4-CTLs) responding to SARS-CoV-2 and reduced proportion of SARS-CoV-2-reactive regulatory T cells (T(REG)). Importantly, in hospitalized COVID-19 patients, a strong cytotoxic T(FH) response was observed early in the illness, which correlated negatively with antibody levels to SARS-CoV-2 spike protein. Polyfunctional T(H)1 and T(H)17 cell subsets were underrepresented in the repertoire of SARS-CoV-2-reactive CD4(+) T cells compared to influenza-reactive CD4(+) T cells. Together, our analyses provide insights into the gene expression patterns of SARS-CoV-2-reactive CD4(+) T cells in distinct disease severities. Published by Elsevier Inc. 2020-11-25 2020-10-05 /pmc/articles/PMC7534589/ /pubmed/33096020 http://dx.doi.org/10.1016/j.cell.2020.10.001 Text en Crown Copyright © 2020 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Meckiff, Benjamin J. Ramírez-Suástegui, Ciro Fajardo, Vicente Chee, Serena J. Kusnadi, Anthony Simon, Hayley Eschweiler, Simon Grifoni, Alba Pelosi, Emanuela Weiskopf, Daniela Sette, Alessandro Ay, Ferhat Seumois, Grégory Ottensmeier, Christian H. Vijayanand, Pandurangan Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19 |
title | Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19 |
title_full | Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19 |
title_fullStr | Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19 |
title_full_unstemmed | Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19 |
title_short | Imbalance of Regulatory and Cytotoxic SARS-CoV-2-Reactive CD4(+) T Cells in COVID-19 |
title_sort | imbalance of regulatory and cytotoxic sars-cov-2-reactive cd4(+) t cells in covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534589/ https://www.ncbi.nlm.nih.gov/pubmed/33096020 http://dx.doi.org/10.1016/j.cell.2020.10.001 |
work_keys_str_mv | AT meckiffbenjaminj imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT ramirezsuasteguiciro imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT fajardovicente imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT cheeserenaj imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT kusnadianthony imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT simonhayley imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT eschweilersimon imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT grifonialba imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT pelosiemanuela imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT weiskopfdaniela imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT settealessandro imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT ayferhat imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT seumoisgregory imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT ottensmeierchristianh imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 AT vijayanandpandurangan imbalanceofregulatoryandcytotoxicsarscov2reactivecd4tcellsincovid19 |